We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Industry Wary of New Packaging For Opioids; Contend it Could Delay Entry
Generic Industry Wary of New Packaging For Opioids; Contend it Could Delay Entry
The generic drug industry wants the FDA to ensure new requirements for packaging and technologies aimed at curbing opioid abuse don’t result in barriers to market entry for generic makers.